Taken together, our results revealed that HOXA5 could target AKR1B10 to increase AKR1B10 level and activate p53 signaling, thereby inhibiting proliferation and inducing apoptosis of ACC cells, ultimately contributing to the suppression of ACC. The gene discussed is TP53; the disease is adrenal cortex carcinoma.